Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · IEX Real-Time Price · USD
1.220
-0.070 (-5.43%)
At close: May 17, 2024, 4:00 PM
1.249
+0.029 (2.38%)
After-hours: May 17, 2024, 7:47 PM EDT

Clearmind Medicine Income Statement

Millions CAD. Fiscal year is Nov - Oct.
Year 2023202220212020
Selling, General & Admin
4.763.172.220.23
Research & Development
1.543.080.470
Operating Expenses
6.36.252.690.23
Operating Income
-6.3-6.25-2.69-0.23
Other Expense / Income
2.30.610.030.18
Pretax Income
-8.6-6.87-2.73-0.41
Income Tax
0.020.0300
Net Income
-8.62-6.89-2.73-0.41
Shares Outstanding (Basic)
0000
Shares Outstanding (Diluted)
0000
Shares Change
367.25%40.19%70.50%-
EPS (Basic)
-42.58-159.11-88.16-22.80
EPS (Diluted)
-42.58-159.11-88.16-22.80
Free Cash Flow
-6.3-3.73-2.1-0.27
Free Cash Flow Per Share
-31.12-86.08-67.98-15.14
EBITDA
-8.55-6.78-2.72-0.41
Depreciation & Amortization
0.060.0800
EBIT
-8.6-6.87-2.73-0.41
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).